Supernus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $42.11 |
Previous Close | $42.64 |
Day Range | $41.76-$42.60 |
52W Range | $29.16-$43.61 |
Market Cap | $2.3B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $665.1M |
Revenue Growth (YoY) | -1.7% |
Gross Profit (12 Mos) | $588.8M |
Diluted EPS | $1.15 |
News
See moreYahoo Finance • 4 days ago
Here’s Third Avenue Small-Cap Value Fund’s Update on Supernus Pharmaceuticals (SUPN)
Yahoo Finance • 8 days ago
Supernus Pharmaceuticals price target raised to $43 from $38 at Stifel
Yahoo Finance • 9 days ago
Supernus raises 2025 revenue guidance to $670M-$700M following Sage acquisition and strong core product growth
Yahoo Finance • 9 days ago
Earnings call transcript: Supernus Q2 2025 revenue beats forecast, EPS misses
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 674 |
